Baliga Juliet Bassiome
Nkwen Medical Center (PMI), Cameroon
Posters & Accepted Abstracts: J Diabetes Metab
Associations between hyperuricemia, metabolic syndrome, cardiovascular disease and diabetes have been reported. However, limited information is available concerning the prevalence and correlates hyperuricemia among adults in Tiko subdivision. This study sought to estimate the prevalence of hyperuricemia and to evaluate its relationship with metabolic syndrome (MetS). A total of 202 participants were enrolled in this study between the May and April 2010 from patients who came for health examination at the CDC Central Clinic Tiko and Regina Pacis Health Centre Mutengene. Hyperuricemia was defined as â?¥7 mg/dl (in men) and â?¥6 mg/ dl (in women). Metabolic syndrome was defined according to World Health Organization, National Cholesterol Education Program- Adult Training Panel III and International Diabetes Federation. The overall prevalence of hyperuricemia was 45% and the condition was more prevalent in females than in males (47.7% vs. 41.9%) and more in the people between the ages of 20-40 years than in those above 40 years (47% vs. 38.9%). The metabolic syndrome had a general prevalence of 28.2%. The IDF definition recorded the highest prevalence of the metabolic syndrome (32.17%) while the WHO definition recorded the lowest (8.42%). Hyperuricemia was related to IDF metabolic syndrome (r=0.22, p=0.001), NCEP-ATPIII metabolic syndrome (r=0.12, p=0.077), WHO metabolic syndrome (r=0.16, p=0.027). Hyperuricemia was most co-related with cholesterol (r=0.236) and HDL (r= -0.151). Hence, hyperuricemia and metabolic syndrome are prevalent among the adult population of Tiko.
Email: julietbaliga@yahoo.com
